Outcome of MS relapses in the era of disease-modifying therapy

BACKGROUND: In multiple sclerosis (MS), neurological disability results from incomplete remission of relapses and from relapse-independent progression. Intravenous high dose methylprednisolone (IVMP) is the established standard treatment to accelerate clinical relapse remission, although some patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoppe, Muriel, Busch, Maria, Krizek, Luise, Then Bergh, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547454/
https://www.ncbi.nlm.nih.gov/pubmed/28784102
http://dx.doi.org/10.1186/s12883-017-0927-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547454/
https://www.ncbi.nlm.nih.gov/pubmed/28784102
http://dx.doi.org/10.1186/s12883-017-0927-x

Ejemplares similares